ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor Tovora…

2024 ASCO® Annual Meeting Insights Hub

D. Ziegler

BRAF in the MAPK Pathway for Pediatric Low-Grade Glioma: Current Tes…

Avani Mangoli

LITT for Deep-Seated Perivascular Brain Tumors: Evaluating the Risk …

Hassan Fadel

Effective Strategies for Managing IDH-Mutant Gliomas

Matteo Simonelli

Biomarkers in Diffuse Midline Glioma

University of Colorado Department of Medicine

A. Green

Pediatric Low Grade Glioma: Radiation in the Targeted Therapy Era

Rene McNall-Knapp

Overview and Updates in Brain Tumors

Henry Friedman

Penn Medicine Updates on Brain Tumors

Penn Medicine Abramson Cancer Center

S. Bagley

Developing Novel Therapeutics for Brain Tumors in the Age of Genomic…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

E. Galanis

Primary Brain Tumors: Targeting Metabolism in Glioma

UNC Lineberger Comprehensive Cancer Center

D. Higgins

IDH-Mutant Diffuse Glioma: Best Practices for Multidisciplinary Appr…

Ruham Nasany

MIPS in Tumor Applications: Deep Brain Lesions a Review of Current S…

Subcortical Surgery Group

K. Chaichana

Should We Treat Seizures Associated With Tumors Differently?

Edward Avila

An Overview of the Opportunities and Barriers in BCI

Subcortical Surgery Group

J. Bailes

Fluorescence-Guided Surgery for Non-Enhancing Tumors

Mount Sinai Fluorescence-Guided Surgery Symposium

N. Sanai

Anterior Petrosectomy for Petroclival Meningioma: Preliminary Experi…

Weill Cornell Medicine Courses and Meetings

C. Hong

New Advances in Minimally Invasive Brain Surgery: What You Need to K…

2020 South Florida Neuroscience Symposium

R. Komotar

Neurosurgical Targets for Chronic Pain

UCLA Health

J. Langevin

Why 5-ALA Fluorescence-Guided Surgery (FGS) for Brain Tumors?

Mount Sinai Fluorescence-Guided Surgery Symposium

C. Hadjipanayis

Electrocorticography and Functional Cortical Mapping

Houston Methodist

A. Verma